Medical professional network Doximity (NYSE: DOCS) will be reporting earnings this Thursday after market hours. Here’s what to expect.
Doximity beat analysts’ revenue expectations last quarter, reporting revenues of $156.6 million, up 7.3% year on year. It was a slower quarter for the company, with EBITDA guidance for next quarter missing analysts’ expectations significantly and a miss of analysts’ billings estimates.
Is Doximity a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Doximity’s revenue to grow 1.6% year on year, slowing from the 23.2% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Doximity has a history of exceeding Wall Street’s expectations.
Looking at Doximity’s peers in the vertical software segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Procore Technologies delivered year-on-year revenue growth of 18.7%, beating analysts’ expectations by 4.8%, and Cadence Design Systems reported revenues up 22%, topping estimates by 1.1%. Cadence Design Systems traded up 6.5% following the results.
Read our full analysis of Procore Technologies’s results here and Cadence Design Systems’s results here.
There has been positive sentiment among investors in the vertical software segment, with share prices up 3.5% on average over the last month. Doximity is up 14% during the same time and is heading into earnings with an average analyst price target of $31.11 (compared to the current share price of $32.59).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
